Last reviewed · How we verify
preoperative 0.5% ropivacaine hydrochloride preoperative — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
preoperative 0.5% ropivacaine hydrochloride preoperative (preoperative 0.5% ropivacaine hydrochloride preoperative) — China Medical University, China.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| preoperative 0.5% ropivacaine hydrochloride preoperative TARGET | preoperative 0.5% ropivacaine hydrochloride preoperative | China Medical University, China | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- preoperative 0.5% ropivacaine hydrochloride preoperative CI watch — RSS
- preoperative 0.5% ropivacaine hydrochloride preoperative CI watch — Atom
- preoperative 0.5% ropivacaine hydrochloride preoperative CI watch — JSON
- preoperative 0.5% ropivacaine hydrochloride preoperative alone — RSS
Cite this brief
Drug Landscape (2026). preoperative 0.5% ropivacaine hydrochloride preoperative — Competitive Intelligence Brief. https://druglandscape.com/ci/preoperative-0-5-ropivacaine-hydrochloride-preoperative. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab